Información del artículo
“E. coli uropatógeno” ha sido el término utilizado para describir las cepas de Escherichia coli capaces de causar infección urinaria (IU). Su caracterización a nivel molecular ha demostrado que son las mismas que causan infección en localizaciones extraintestinales no-urinarias, y se propone la designación más inclusiva de “E. coli patógeno extraintestinal” o ExPEC. Los ExPEC derivan principalmente del grupo filogenético B2 y albergan genes que codifican factores de virulencia, como fimH, papA, papG alelo II, kspM II, hlyA, cnf1, fyuA, iutA o traT, agrupados en islas de patogenicidad o PAI. El ecosistema vaginal, y en especial Lactobacillus, así como las poblaciones intestinales de E. coli, el coito y las condiciones fisiológicas y anatómicas del tracto urinario, desempeñan también un papel importante en la patogenia de la IU. La persistencia de E. coli en las biopelículas o pods vesicales o en el reservorio fecal podría explicar las infecciones recurrentes en mujeres jóvenes.
Palabras clave:
Infección urinaria
Patogenia
Escherichia coli
Factores de virulencia
Adhesinas
“Uropathogenic Escherichia coli” has been the term used to describe E. coli strains able to cause urinary tract infections. Their molecular characterization has demonstrated that these strains are the same as those causing infections in non-urinary extaintestinal locations, and it has been proposed thus the more inclusive term “extraintestinal pathogenic E. coli” or “ExPEC” to use. ExPEC derive mainly from the phylogenetic B2 group and harbor genes that codify virulence, such as fimH, papA, papG allele II, kspM II, hlyA, cnf1, fyuA, iutA, and traT, which are grouped in pathogenicity islands (PAIs). The vaginal ecosystem and especially Lactobacillus, as well as intestinal populations of E. coli, coitus and the physiological and anatomical conditions of the urinary tract also play a major role in the pathogenesis of urinary tract infections. The persistence of E. coli in bladder “biofilms” or “pods” or in the fecal reservoir could explain recurrent infections in young women.
Key words:
Urinary infection
Pathogenesis
Escherichia coli
Virulence factors
Adhesins
El Texto completo está disponible en PDF
Bibliografía
[1.]
A. Andreu.
Infecciones urinarias: aspectos puntuales.
Enferm Infecc Microbiol Clin, 13 (1995), pp. 527-531
[2.]
T.M. Hooton, D. Scholes, J.P. Hughes.
A prospective study of risk factors for symptomatic urinary tract infection in young women.
N Engl J Med, 335 (1996), pp. 468-474
[3.]
W.E. Stamm, R. Raz.
Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections.
Clin Infect Dis, 28 (1999), pp. 723-725
[4.]
R. Raz, Y. Gennesin, J. Wasser, Z. Stoler, S. Rosenfeld, S. Rottensterich, et al.
Recurrent urinary tract infections in postmenopausal women.
Clin Infect Dis, 30 (2000), pp. 152-156
[5.]
D. Scholes, T.M. Hooton, P.L. Roberts, A.E. Stapleton, K. Gupta, W.E. Stamm.
Risk factors for recurrent urinary tract infection in young women.
J Infect Dis, 182 (2000), pp. 1177-1182
[6.]
J.R. Johnson.
Evolution of pathogenic Escherichia coli.
Escherichia coli: virulence mechanism of a versatil pathogen, Elsevier Science (USA), (2002),
[7.]
A. Andreu, A. Stapleton, C. Fennell, H.A. Lockman, M. Xercavins, F. Fernández, et al.
Urovirulence determinants of Escherichia coli strains causing prostatitis.
J Infect Dis, 176 (1997), pp. 464-467
[8.]
J.R. Johnson, A.L. Stell.
Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.
J Infect Dis, 181 (2000), pp. 261-272
[9.]
E. Moreno, I. Planells, P. Prats, A.M. Planes, G. Moreno, A. Andreu.
Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia vs. strains causing pyelonephritis and other sources of bacteremia.
Diag Microbiol Infec Dis, 53 (2005), pp. 43-49
[10.]
Sabaté M, Moreno E, Pérez T, Andreu A, Prats G. Detection of pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. J CMI. Pendiente de aceptación.
[11.]
B. Picard, J. Sevali, S. Gouriou, P. Duriez, N. Brahimi, E. Bingen, et al.
The link between phylogeny and virulence in Escherichia coli extraintestinal infection.
Infect Immun, 67 (1999), pp. 546-553
[12.]
T.A. Russo, J.R. Johnson.
Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.
J Infect Dis, 181 (2000), pp. 1753-1754
[13.]
I. Phillips, S. Eykyn, A. King, W.R. Gransden, B. Rowe, J.A. Frost, et al.
Epidemic multirresistant Escherichia coli infection in West Lambeth Health District.
Lancet, 1 (1988), pp. 1038-1041
[14.]
G. Prats, F. Navarro, B. Mirelis, D. Dalmau, N. Margall, P. Coll, et al.
Escherichia coli serotype 015:K52:H1 as a uropathogenic clone.
J Clin Microbiol, 8 (2000), pp. 201-209
[15.]
A.R. Manges, J.R. Johnson, B. Foxman, T.T. O’Bryan, K.E. Fullerton, L. Riley.
Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.
N Engl J Med, 345 (2001), pp. 1007-1013
[16.]
M.J. Balish, J. Jensen, D.T. Uehling.
Bladder mucin: a scanning electron microscopy study experimental cystitis.
J Urol, 128 (1982), pp. 1060-1063
[17.]
C.S. Hung, J. Bouckaert, D. Hung, J. Pinkner, C. Widberg, A. DeFusco.
Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection.
Mol Microbiol, 44 (2002), pp. 903-915
[18.]
M.A. Mulvey, Y.S. López-Boado, C.L. Wilson, R. Roth, W.C. Parks, J. Heuser, et al.
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
Science, 282 (1998), pp. 1494-1497
[19.]
G.G. Andreson, J.J. Palermo, J.D. Schilling, R. Roth, J. Heuser, S.J. Hultgren.
Intracellular bacterial biofilm-like pods in urinary tract infections.
Science, 301 (2003), pp. 105-107
[20.]
Pérez T, Andreu A, Sabaté M, Moreno E, Prats G. Sub-mic effects of fosfomycin and ciprofloxacin on the expression of type-1 fimbriae in Escherichia coli. Proceedings of the 7th European Congress of Chemotherapy and Infection. 19-22 Octubre 2005; Florencia, Italia. Poster 1849.
[21.]
A. Stapleton.
Novel approaches to prevention of urinary tract infections.
Infect Dis Clin N Am, 17 (2003), pp. 457-471
[22.]
U. Dobrindt, G. Blum-Oehler, G. Nagy, G. Schneider, A. Johann, G. Gottschalk, et al.
Genetic structure and distribution of four pathogenicity islands (PAI I536 to PAI IV536) of uropathogenic Escherichia coli strain 536.
Infect Immun, 270 (2000), pp. 6365-6372
[23.]
J. Hacker, J.B. Kaper.
Pathogenicity islands and the evolution of microbes.
Annu Rev Microbiol, 54 (2000), pp. 641-679
[24.]
R. Raz, W.E. Stamm.
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
N Engl J Med, 329 (1993), pp. 753-756
[25.]
M.AD. Antonio, S.E. Hawes, S.L. Hillier.
The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species.
J Infect Dis, 180 (1999), pp. 1950-1956
[26.]
A. Vásquez, T. Jakobson, S. Ahrné, U. Forsum, G. Molin.
Vaginal Lactobacillus flora of healthy Swedish women.
J Clin Microbiol, 40 (2002), pp. 2746-2749
[27.]
G. Reid, R.L. Cook, A.W. Bruce.
Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract.
J Urol, 138 (1987), pp. 330-335
[28.]
A. Andreu, A.E. Stapleton, C.L. Fennel, S.L. Hillier, W.E. Stamm.
Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species.
J Infect Dis, 171 (1995), pp. 1237-1240
[29.]
J. Osset, R.M. Bartolomé, E. García, A. Andreu.
Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells.
J Inf Dis, 183 (2001), pp. 485-491
[30.]
R.N. Gruneberg.
Relationship of infecting urinary organism to the faecal flora in patients with sympomatic urinary infection.
Lancet, 2 (1969), pp. 766-768
[31.]
S. Yamamoto, T. Tsukamoto, A. Terai, H. Kurazono, Y. Takeda, O. Yoshida.
Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli.
J Urol, 157 (1997), pp. 1127-1129
[32.]
M. Turck, R.G. Petersdorf.
The epidemiology of nonenteric Escherichia coli infections: prevalence of serological groups.
J Clin Invest, 41 (1962), pp. 1760-1765
[33.]
K. Plos, H. Connell, U. Jodal, B.I. Marklund, S. Marild, B. Wettergren, et al.
Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children.
J Infect Dis, 171 (1995), pp. 625-631
[34.]
I.M. Johanson, K. Plos, B.I. Marklund, C. Svanborg.
Pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract.
Microb Pathog, 15 (1993), pp. 121-129
[35.]
J.R. Johnson.
Virulence factors in Escherichia coli urinary tract infection.
Clin Microbiol Rev, 4 (1991), pp. 80-128
[36.]
J.R. Johnson.
Microbial virulence determinants and the pathogenesis of urinary tract infection.
Infect Dis Clin North Am, 17 (2003), pp. 261-278
[37.]
T.A. Schalger, J.O. Hendley, A.L. Bell, T.S. Whittam.
Clonal diversity of Escherichia coli colonizing stools and urinary tracts of young girls.
Infect Immun, 70 (2002), pp. 1225-1229
[38.]
T.A. Schalger, T.S. Whittam, J.O. Hendley, J.L. Bhang, C.L. Wobbe, A. Stapleton.
Variation in frequency of the virulence-factor gene in Escherichia coli clones colonizing the stools and urinary tracts of healthy prepubertal girls.
J Infect Dis, 188 (2003), pp. 1059-1064
[39.]
Moreno E, Andreu A, Pérez T, Sabaté M, Johnson JR, Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant fecal flora of the same hosts. Epidem Infect. En prensa.
[40.]
A. Stapleton, M.R. Stroud, S.I. Hakamori, W.E. Stamm.
The globoseries glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissues and is a preferred binding receptor in vitro for uropathogenic Escherichia coli expressing pap-encoded adhesions.
Infect Immun, 66 (1999), pp. 3856-3861
Copyright © 2005. Elsevier España S.L.. Todos los derechos reservados
